DIAMOND BIOFUND INC (6901) - Total Liabilities
Based on the latest financial reports, DIAMOND BIOFUND INC (6901) has total liabilities worth NT$137.79 Million TWD (≈ $4.34 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 6901 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
DIAMOND BIOFUND INC - Total Liabilities Trend (2019–2025)
This chart illustrates how DIAMOND BIOFUND INC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 6901 current and non-current assets.
DIAMOND BIOFUND INC Competitors by Total Liabilities
The table below lists competitors of DIAMOND BIOFUND INC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kec Corporation
KO:092220
|
Korea | ₩110.89 Billion |
|
Chengdu Dahongli Machinery Co Ltd
SHE:300865
|
China | CN¥250.67 Million |
|
OceanPact Serviços Marítimos S.A
SA:OPCT3
|
Brazil | R$2.46 Billion |
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
USA | $75.97 Million |
|
Chongqing Mas Sci&Tech
SHE:300275
|
China | CN¥378.41 Million |
|
Zhejiang Tongli Transmission Technology Co. Ltd. A
SHE:301255
|
China | CN¥511.87 Million |
|
WinMate Communication INC
TW:3416
|
Taiwan | NT$1.97 Billion |
|
Beijing Bashi Media Co Ltd
SHG:600386
|
China | CN¥2.08 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down DIAMOND BIOFUND INC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 6901 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 112.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DIAMOND BIOFUND INC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DIAMOND BIOFUND INC (2019–2025)
The table below shows the annual total liabilities of DIAMOND BIOFUND INC from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$137.79 Million ≈ $4.34 Million |
-54.31% |
| 2024-12-31 | NT$301.55 Million ≈ $9.50 Million |
+67.77% |
| 2023-12-31 | NT$179.74 Million ≈ $5.66 Million |
+24.77% |
| 2022-12-31 | NT$144.06 Million ≈ $4.54 Million |
-37.59% |
| 2021-12-31 | NT$230.82 Million ≈ $7.27 Million |
+28.12% |
| 2020-12-31 | NT$180.16 Million ≈ $5.68 Million |
+162.35% |
| 2019-12-31 | NT$68.67 Million ≈ $2.16 Million |
-- |
About DIAMOND BIOFUND INC
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.